{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:19:49Z","timestamp":1784107189848,"version":"3.55.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.biomaterials.2021.120974","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T18:33:06Z","timestamp":1623868386000},"page":"120974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Convection enhanced delivery of light responsive antigen capturing oxygen generators for chemo-phototherapy triggered adaptive immunity"],"prefix":"10.1016","volume":"275","author":[{"given":"Vishnu","family":"Sunil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anbu","family":"Mozhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0268-5042","authenticated-orcid":false,"given":"Wenbo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Heng","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1040-2121","authenticated-orcid":false,"given":"Chi-Hwa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2021.120974_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jnci.2016.07.001","article-title":"Management of glioblastoma after recurrence: a changing paradigm","volume":"28","author":"Mallick","year":"2016","journal-title":"J. Egypt. Natl. Canc. Inst."},{"key":"10.1016\/j.biomaterials.2021.120974_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2015.05.005","article-title":"Glioblastoma multiforme: pathogenesis and treatment","volume":"152","author":"Alifieris","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.120974_bib3","first-page":"1365","article-title":"High-density lipoprotein-mimicking nanodiscs for chemo-immunotherapy against glioblastoma multiforme","volume":"13","author":"Kadiyala","year":"2019","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.biomaterials.2021.120974_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.biomaterials.2021.120974_bib5","first-page":"5132","article-title":"Proliferative activity of intratumoral CD8+ T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity","volume":"61","author":"Nakano","year":"2001","journal-title":"Canc. Res."},{"issue":"10","key":"10.1016\/j.biomaterials.2021.120974_bib6","first-page":"3932","article-title":"Prognostic significance of activated CD8+ T cell infiltrations within esophageal carcinomas","volume":"61","author":"Schumacher","year":"2001","journal-title":"Canc. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.120974_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40425-018-0389-8","article-title":"Design considerations for early-phase clinical trials of immune-oncology agents","volume":"6","author":"Wages","year":"2018","journal-title":"Journal for immunotherapy of cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.120974_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.immuni.2013.06.014","article-title":"Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance","volume":"39","author":"Zitvogel","year":"2013","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120974_bib9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Canc."},{"issue":"26","key":"10.1016\/j.biomaterials.2021.120974_bib10","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.biomaterials.2021.120974_bib11","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.molmed.2018.05.004","article-title":"Beyond cell death: new functions for TNF family cytokines in autoimmunity and tumor immunotherapy","volume":"24","author":"Yi","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biomaterials.2021.120974_bib12","series-title":"CAR-T Cell Therapy: from the Bench to the Bedside","author":"Golubovskaya","year":"2017"},{"key":"10.1016\/j.biomaterials.2021.120974_bib13","series-title":"CAR-T Cell Therapy Seeks Strategies to Harness Cytokine Storm","author":"DeFrancesco","year":"2014"},{"issue":"3","key":"10.1016\/j.biomaterials.2021.120974_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrclinonc.2010.223","article-title":"Immune parameters affecting the efficacy of chemotherapeutic regimens","volume":"8","author":"Zitvogel","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.120974_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/neuonc\/noq157","article-title":"Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma","volume":"13","author":"Sampson","year":"2011","journal-title":"Neuro Oncol."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120974_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br. J. Canc."},{"issue":"5","key":"10.1016\/j.biomaterials.2021.120974_bib17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2004.09.009","article-title":"Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells","volume":"21","author":"Kim","year":"2004","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.biomaterials.2021.120974_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1084\/jem.191.3.411","article-title":"The induction of tolerance by dendritic cells that have captured apoptotic cells","volume":"191","author":"Steinman","year":"2000","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.120974_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/jlb.66.2.345","article-title":"Delayed clearance of apoptotic lymphoma cells allows cross\u2010presentation of intracellular antigens by mature dendritic cells","volume":"66","author":"Rovere","year":"1999","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.biomaterials.2021.120974_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0609.1993.tb00165.x","article-title":"Severe immunodeficiency in patients treated with fludarabine monophosphate","volume":"50","author":"Wijermans","year":"1993","journal-title":"Eur. J. Haematol."},{"issue":"5","key":"10.1016\/j.biomaterials.2021.120974_bib21","first-page":"1725","article-title":"Prevention of myelosuppression does not improve the therapeutic efficacy of chemo-immunotherapy","volume":"12","author":"Lumsden","year":"1992","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2021.120974_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0897190014546108","article-title":"Antineoplastic agents and the associated myelosuppressive effects: a review","volume":"27","author":"Barreto","year":"2014","journal-title":"J. Pharm. Pract."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.120974_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2021.120974_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2545","article-title":"Immunogenic and tolerogenic cell death","volume":"9","author":"Green","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.biomaterials.2021.120974_bib25","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1021\/acs.nanolett.9b02306","article-title":"Redox-activated porphyrin-based liposome remote-loaded with indoleamine 2, 3-dioxygenase (ido) inhibitor for synergistic photoimmunotherapy through induction of immunogenic cell death and blockage of ido pathway","volume":"19","author":"Liu","year":"2019","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.120974_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"issue":"25","key":"10.1016\/j.biomaterials.2021.120974_bib27","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.7150\/thno.38425","article-title":"Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy","volume":"9","author":"Lim","year":"2019","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.biomaterials.2021.120974_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7150\/thno.29026","article-title":"Low molecular weight heparin-coated and dendrimer-based core-shell nanoplatform with enhanced immune activation and multiple anti-metastatic effects for melanoma treatment","volume":"9","author":"Xia","year":"2019","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.biomaterials.2021.120974_bib29","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.7150\/thno.24699","article-title":"DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells","volume":"8","author":"Laengle","year":"2018","journal-title":"Theranostics"},{"issue":"6230","key":"10.1016\/j.biomaterials.2021.120974_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120974_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/MO:18:4:243","article-title":"Treatment resistance of solid tumors","volume":"18","author":"Vaupel","year":"2001","journal-title":"Med. Oncol."},{"issue":"10","key":"10.1016\/j.biomaterials.2021.120974_bib32","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1021\/acs.nanolett.8b02720","article-title":"Self-supplied tumor oxygenation through separated liposomal delivery of H2O2 and catalase for enhanced radio-immunotherapy of cancer","volume":"18","author":"Song","year":"2018","journal-title":"Nano Lett."},{"issue":"19","key":"10.1016\/j.biomaterials.2021.120974_bib33","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jnci\/djm135","article-title":"Drug resistance and the solid tumor microenvironment","volume":"99","author":"Tr\u00e9dan","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biomaterials.2021.120974_bib34","series-title":"Tumor Microenvironmental Physiology and its Implications for Radiation Oncology, Seminars in Radiation Oncology","first-page":"198","author":"Vaupel","year":"2004"},{"issue":"5","key":"10.1016\/j.biomaterials.2021.120974_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1269\/jrr.11056","article-title":"How can we overcome tumor hypoxia in radiation therapy?","volume":"52","author":"Harada","year":"2011","journal-title":"J. Radiat. Res."},{"issue":"21","key":"10.1016\/j.biomaterials.2021.120974_bib36","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1158\/0008-5472.CAN-11-3666","article-title":"CD24 is an effector of HIF-1\u2013driven primary tumor growth and metastasis","volume":"72","author":"Thomas","year":"2012","journal-title":"Canc. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.120974_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.biomaterials.2021.120974_bib38","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.biomaterials.2021.120974_bib39","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1172\/JCI84427","article-title":"The impact of hypoxia on tumor-associated macrophages","volume":"126","author":"Henze","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"14","key":"10.1016\/j.biomaterials.2021.120974_bib40","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/adma.201504617","article-title":"Perfluorocarbon\u2010loaded hollow Bi2Se3 nanoparticles for timely supply of oxygen under near\u2010infrared light to enhance the radiotherapy of cancer","volume":"28","author":"Song","year":"2016","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.120974_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms9785","article-title":"Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy","volume":"6","author":"Cheng","year":"2015","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2021.120974_bib42","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1021\/acsnano.6b04156","article-title":"Carbon-dot-decorated carbon nitride nanoparticles for enhanced photodynamic therapy against hypoxic tumor via water splitting","volume":"10","author":"Zheng","year":"2016","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.biomaterials.2021.120974_bib43","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1021\/acs.biomac.5b00571","article-title":"Synthesis of hemoglobin conjugated polymeric micelle: a ZnPc carrier with oxygen self-compensating ability for photodynamic therapy","volume":"16","author":"Wang","year":"2015","journal-title":"Biomacromolecules"},{"issue":"28","key":"10.1016\/j.biomaterials.2021.120974_bib44","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1002\/adma.201405141","article-title":"Intelligent MnO2 nanosheets anchored with upconversion nanoprobes for concurrent pH\u2010\/H2O2\u2010responsive UCL imaging and oxygen\u2010elevated synergetic therapy","volume":"27","author":"Fan","year":"2015","journal-title":"Adv. Mater."},{"issue":"36","key":"10.1016\/j.biomaterials.2021.120974_bib45","doi-asserted-by":"crossref","first-page":"11522","DOI":"10.1002\/anie.201805138","article-title":"Innovative strategies for hypoxic\u2010tumor photodynamic therapy","volume":"57","author":"Li","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120974_bib46","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/acs.nanolett.6b00068","article-title":"Hyaluronidase to enhance nanoparticle-based photodynamic tumor therapy","volume":"16","author":"Gong","year":"2016","journal-title":"Nano Lett."},{"issue":"16","key":"10.1016\/j.biomaterials.2021.120974_bib47","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1021\/jacs.6b01784","article-title":"An implantable depot that can generate oxygen in situ for overcoming hypoxia-induced resistance to anticancer drugs in chemotherapy","volume":"138","author":"Huang","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2021.120974_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.05.025","article-title":"Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer","volume":"138","author":"Zhang","year":"2017","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biomaterials.2021.120974_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nature reviews materials"},{"issue":"7","key":"10.1016\/j.biomaterials.2021.120974_bib50","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0169-409X(02)00054-6","article-title":"Local drug delivery to the brain","volume":"54","author":"Wang","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2021.120974_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijpharm.2012.06.025","article-title":"Drug delivery strategies for the treatment of malignant gliomas","volume":"436","author":"Allhenn","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.biomaterials.2021.120974_bib52","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/cgt.2013.25","article-title":"Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model","volume":"20","author":"Yin","year":"2013","journal-title":"Canc. Gene Ther."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.120974_bib53","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/cancers5031020","article-title":"Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM?","volume":"5","author":"Van Woensel","year":"2013","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2021.120974_bib54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2017.12.020","article-title":"Convection enhanced delivery of chemotherapeutic drugs into brain tumour","volume":"271","author":"Zhan","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2021.120974_bib55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2018.07.006","article-title":"Convection enhanced delivery of liposome encapsulated doxorubicin for brain tumour therapy","volume":"285","author":"Zhan","year":"2018","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.120974_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40425-015-0053-5","article-title":"New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy","volume":"3","author":"Guo","year":"2015","journal-title":"Journal for immunotherapy of cancer"},{"issue":"9","key":"10.1016\/j.biomaterials.2021.120974_bib57","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1158\/0008-5472.CAN-16-2832","article-title":"Local activation of p53 in the tumor microenvironment overcomes immune suppression and enhances antitumor immunity","volume":"77","author":"Guo","year":"2017","journal-title":"Canc. Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120974_bib58","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.humimm.2012.01.018","article-title":"The MDM2 inhibitor Nutlin-3 modulates dendritic cell\u2013induced T cell proliferation","volume":"73","author":"Gasparini","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.biomaterials.2021.120974_bib59","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jconrel.2020.05.005","article-title":"Enhanced penetration of pro-apoptotic and anti-angiogenic micellar nanoprobe in 3D multicellular spheroids for chemophototherapy","volume":"323","author":"Mozhi","year":"2020","journal-title":"J. Contr. Release"},{"issue":"20","key":"10.1016\/j.biomaterials.2021.120974_bib60","doi-asserted-by":"crossref","first-page":"10832","DOI":"10.1039\/C6NR02174C","article-title":"\u201cSheddable\u201d PEG-lipid to balance the contradiction of PEGylation between long circulation and poor uptake","volume":"8","author":"Zhao","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2021.120974_bib61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2014.03.026","article-title":"PEG\u2013PLGA copolymers: their structure and structure-influenced drug delivery applications","volume":"183","author":"Zhang","year":"2014","journal-title":"J. Contr. Release"},{"issue":"17","key":"10.1016\/j.biomaterials.2021.120974_bib62","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1039\/C4CS00487F","article-title":"Nanoparticle colloidal stability in cell culture media and impact on cellular interactions","volume":"44","author":"Moore","year":"2015","journal-title":"Chem. Soc. Rev."},{"issue":"18","key":"10.1016\/j.biomaterials.2021.120974_bib63","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.7150\/thno.19546","article-title":"pH-responsive aerobic nanoparticles for effective photodynamic therapy","volume":"7","author":"Shen","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2021.120974_bib64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.mie.2016.02.016","article-title":"Intense PEGylation of enzyme surfaces: relevant stabilizing effects","volume":"571","author":"Moreno-P\u00e9rez","year":"2016","journal-title":"Methods Enzymol."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120974_bib65","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nnano.2015.330","article-title":"Protein adsorption is required for stealth effect of poly (ethylene glycol)-and poly (phosphoester)-coated nanocarriers","volume":"11","author":"Sch\u00f6ttler","year":"2016","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.120974_bib66","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13046-017-0570-9","article-title":"Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids","volume":"36","author":"Riffle","year":"2017","journal-title":"J. Exp. Clin. Canc. Res."},{"issue":"37","key":"10.1016\/j.biomaterials.2021.120974_bib67","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41388-018-0317-x","article-title":"Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer","volume":"37","author":"Al Habyan","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.120974_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.cr.7290206","article-title":"The cell cycle related apoptotic susceptibility to arsenic trioxide is associated with the level of reactive oxygen species","volume":"14","author":"Gao","year":"2004","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120974_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018588","article-title":"Activation of p53 by nutlin-3a induces apoptosis and cellular senescence in human glioblastoma multiforme","volume":"6","author":"Villalonga-Planells","year":"2011","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.biomaterials.2021.120974_bib70","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/abbs\/gms053","article-title":"MDM2 inhibitor Nutlin-3a suppresses proliferation and promotes apoptosis in osteosarcoma cells","volume":"44","author":"Wang","year":"2012","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"6","key":"10.1016\/j.biomaterials.2021.120974_bib71","first-page":"2113","article-title":"Analysis of apoptotic effects induced by photodynamic therapy in a human biliary cancer cell line","volume":"30","author":"Nonaka","year":"2010","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.120974_bib72","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/cr.2010.19","article-title":"Endocytosis unplugged: multiple ways to enter the cell","volume":"20","author":"Kumari","year":"2010","journal-title":"Cell Res."},{"issue":"5922","key":"10.1016\/j.biomaterials.2021.120974_bib73","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.biomaterials.2021.120974_bib74","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nnano.2017.113","article-title":"Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy","volume":"12","author":"Min","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"5121","key":"10.1016\/j.biomaterials.2021.120974_bib75","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1126\/science.7688139","article-title":"Differential T cell costimulatory requirements in CD28-deficient mice","volume":"261","author":"Shahinian","year":"1993","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biomaterials.2021.120974_bib76","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1590\/S0100-879X2012007500061","article-title":"Co-culture of apoptotic breast cancer cells with immature dendritic cells: a novel approach for DC-based vaccination in breast cancer","volume":"45","author":"Zheng","year":"2012","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"15\u201316","key":"10.1016\/j.biomaterials.2021.120974_bib77","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.molimm.2011.04.018","article-title":"Interactions of dendritic cells with cancer cells and modulation of surface molecules affect functional properties of CD8+ T cells","volume":"48","author":"Seo","year":"2011","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.biomaterials.2021.120974_bib78","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1158\/1078-0432.CCR-12-3314","article-title":"Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages","volume":"19","author":"Bloch","year":"2013","journal-title":"Clin. Canc. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.120974_bib79","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2008.00635.x","article-title":"Strategies for use of IL\u201010 or its antagonists in human disease","volume":"223","author":"O'Garra","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biomaterials.2021.120974_bib80","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fimmu.2013.00177","article-title":"Unique versus redundant functions of IL-1\u03b1 and IL-1\u03b2 in the tumor microenvironment","volume":"4","author":"Voronov","year":"2013","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.biomaterials.2021.120974_bib81","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1073\/pnas.0902745106","article-title":"IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation","volume":"106","author":"Ben-Sasson","year":"2009","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"33","key":"10.1016\/j.biomaterials.2021.120974_bib82","doi-asserted-by":"crossref","first-page":"9224","DOI":"10.1016\/j.biomaterials.2014.07.050","article-title":"Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms","volume":"35","author":"Shahbazi","year":"2014","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2021.120974_bib83","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1112941","article-title":"Antitumor cytotoxicity induced by bone-marrow-derived antigen-presenting cells is facilitated by the tumor suppressor protein p53 via regulation of IL-12","volume":"5","author":"Slatter","year":"2016","journal-title":"OncoImmunology"},{"issue":"11","key":"10.1016\/j.biomaterials.2021.120974_bib84","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2174\/0929866521666140807115629","article-title":"Mathematical modelling of drug transport and uptake in a realistic model of solid tumour","volume":"21","author":"Zhan","year":"2014","journal-title":"Protein Pept. Lett."},{"issue":"9","key":"10.1016\/j.biomaterials.2021.120974_bib85","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1039\/C5IB00088B","article-title":"Intrinsic and induced drug resistance mechanisms: in silico investigations at the cellular and tissue scales","volume":"7","author":"Liu","year":"2015","journal-title":"Integrative Biology"},{"issue":"13","key":"10.1016\/j.biomaterials.2021.120974_bib86","first-page":"4971","article-title":"Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging","volume":"61","author":"Mardor","year":"2001","journal-title":"Canc. Res."},{"issue":"21","key":"10.1016\/j.biomaterials.2021.120974_bib87","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.1021\/la0257337","article-title":"Interaction of anionic superparamagnetic nanoparticles with cells: kinetic analyses of membrane adsorption and subsequent internalization","volume":"18","author":"Wilhelm","year":"2002","journal-title":"Langmuir"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120974_bib88","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jtbi.2005.06.037","article-title":"Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations","volume":"238","author":"de Pillis","year":"2006","journal-title":"J. Theor. Biol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221003306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221003306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:10:13Z","timestamp":1758906613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961221003306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":88,"alternative-id":["S0142961221003306"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120974","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Convection enhanced delivery of light responsive antigen capturing oxygen generators for chemo-phototherapy triggered adaptive immunity","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120974","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120974"}}